Endophenotypes for Age-Related Macular Degeneration: Extending Our Reach into the Preclinical Stages of Disease

The key to reducing the individual and societal burden of age-related macular degeneration (AMD)-related vision loss, is to be able to initiate therapies that slow or halt the progression at a point that will yield the maximum benefit while minimizing personal risk and cost. There is a critical need...

Full description

Bibliographic Details
Main Authors: Michael B. Gorin, Daniel E. Weeks, Robert V. Baron, Yvette P. Conley, Maria C. Ortube, Steven Nusinowitz
Format: Article
Language:English
Published: MDPI AG 2014-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:http://www.mdpi.com/2077-0383/3/4/1335